I am trying to understand a publication: Tumor cell-selective apoptosis induction through targeting of kv10.1 via bifunctional TRAIL antibody of Franziska Hartung and al 2001 (Molecular cancer)
And I have not got the difference between these two conditions?
Can you help me please? Thank you
http://www.ncbi.nlm.nih.gov/pubmed/?term=scfv62+trail